BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34136986)

  • 1. Effect of Pulsed Direct Current on Iontophoretic Delivery of Pramipexole across Human Epidermal Membrane In Vitro.
    Saepang K; Li SK; Chantasart D
    Pharm Res; 2021 Jul; 38(7):1187-1198. PubMed ID: 34136986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane.
    Saepang K; Li SK; Chantasart D
    Pharm Res; 2021 Apr; 38(4):657-668. PubMed ID: 33826056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive and iontophoretic transport of pramipexole dihydrochloride across human skin microchannels created by microneedles in vitro.
    Saepang K; Li SK; Chantasart D
    Int J Pharm; 2021 Nov; 609():121092. PubMed ID: 34530098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
    Yan G; Li SK; Higuchi WI
    J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
    Ita KB; Banga AK
    Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo.
    Singhal M; Serna C; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2021 Sep; 166():175-181. PubMed ID: 34175373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
    Nugroho AK; Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: Depicting temporal variation and biodistribution in the skin.
    Singhal M; Serna C; Kalaria D; Kalia YN
    Int J Pharm; 2021 Apr; 599():120445. PubMed ID: 33675928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
    Chen Y; Alberti I; Kalia YN
    Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.
    Xu Q; Ibrahim SA; Higuchi WI; Li SK
    Int J Pharm; 2009 Mar; 369(1-2):105-13. PubMed ID: 19041698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedle Mediated Iontophoretic Delivery of Tofacitinib Citrate.
    Dandekar AA; Garimella HT; German CL; Banga AK
    Pharm Res; 2023 Mar; 40(3):735-747. PubMed ID: 35174431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
    Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
    J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
    Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
    J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis.
    Rastogi SK; Singh J
    Pharm Dev Technol; 2005; 10(1):97-104. PubMed ID: 15776817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.